The experimental group also showed significant pre - / posttreatment improvements in both lower limbs in gait dorsiflexion ROAM ( 95 % CI , 1.02-2 .49 ) , cadence ( 95 % CI , 3.45-1 .47 ) , stride length ( 95 % CI , 21.48-10 .83 ) , step length ( 95 % CI , 1.68-6 .61 ) , stance phase ( 95 % CI , 61-107 ) , and foot ( 95 % CI , .56 -.92 ) and malleolus ( 95 % CI , 1.15-1 .63 ) circumference .